Literature DB >> 6743486

Correction equation for ECG time intervals.

A W Kelman, B Whiting, D J Summer.   

Abstract

Mesh:

Year:  1984        PMID: 6743486      PMCID: PMC1463569          DOI: 10.1111/j.1365-2125.1984.tb05036.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Relationship between the pharmacokinetics and pharmacodynamics of procainamide.

Authors:  R L Galeazzi; L Z Benet; L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1976-09       Impact factor: 6.875

2.  Systolic time intervals in heart failure in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Circulation       Date:  1968-02       Impact factor: 29.690

3.  The prediction of individual systolic time interval v heart rate regression equations.

Authors:  A W Kelman; D J Sumner; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

4.  Systolic time interval v heart rate regression equations using atropine: reproducibility studies.

Authors:  A W Kelman; D J Sumner; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

5.  Measurement of systolic time intervals.

Authors:  A W Kelman; D J Sumner; J R Lawrence; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

6.  The QT interval and cycle length: the influence of atropine, hyoscine and exercise.

Authors:  D H Staniforth
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

  6 in total
  4 in total

1.  Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity.

Authors:  D Rousson; J Galleyrand; M Silie; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Relation of human cardiac action potential duration to the interval between beats: implications for the validity of rate corrected QT interval (QTc).

Authors:  W A Seed; M I Noble; P Oldershaw; R B Wanless; A J Drake-Holland; D Redwood; S Pugh; C Mills
Journal:  Br Heart J       Date:  1987-01

3.  The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.

Authors:  D J Stott; A R Saniabadi; J Hosie; G D Lowe; S G Ball
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?

Authors:  D W Harron; D P Nicholls; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.